
Moncef Slaoui, head of the government’s effort to develop a vaccine against Covid-19, says he expects the vaccine to have efficacy rates “in the 90%” range — but that there might not be enough vaccine available for all Americans until the end of next year.
More Stories
Record Korean Cases; Trader’s Guide to Rollout: Virus Update
California Hits Record; Trader’s Guide to Rollout: Virus Update
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push